C+
N+ Score76
Vitamins & MineralsServing: 1 Tablet(s)Type: Vitamin

Methyl B12 by Ortho Molecular Products is a targeted vitamin supplement, focusing on two essential B vitamins with only 2 total ingredients, demonstrating clear label transparency. It holds an N+ Score of 76, receiving a C+ grade, which suggests a good, focused formulation. Both Folate (1000mcg) and Vitamin B12 (5000mcg) are provided at clinically studied dosages, which research suggests may support nerve function, red blood cell formation, and energy metabolism. This product is ideal for individuals specifically looking to supplement with high-dose, bioavailable forms of Folate and Vitamin B12, without additional compounds.

About This Product

Methyl B12 by Ortho Molecular Products is a vitamins & minerals supplement containing 2 active ingredients. It has earned an N+ Score of 76/100 (Grade C+).

This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.

Notable clinical-dose ingredients include Folate, Vitamin B12.

N+ Score Breakdown

Ingredient Adequacy100/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness50/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity42/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Key ingredients at clinically effective doses
  • +Fully transparent label with individual ingredient amounts disclosed
  • +2 ingredient(s) at clinical dose levels

Weaknesses

  • −No major weaknesses identified

Ingredient Analysis (2 ingredients)

IngredientAmountDose Adequacy
Folate1000.000 mcgOptimal
Vitamin B125000.000 mcgOptimal

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.